NeuroSense Therapeutics Ltd - Warrant — Cash Flow (NASDAQ:NRSNW)

Financials

Cash from operating activities 1.54 M7.59 M8.45 M-10.13 M-7.67 M — Cash from investing activities 17 K3.54 M3.65 M1 000-8 000 — Cash from financing activities 11.9 M3.69 M3.9 M10.91 M4.43 M — Free cash flow 1.54 M7.59 M8.45 M-10.14 M-7.68 M —